Bellwether Advisors, LLC Merck & Co., Inc. Transaction History

Bellwether Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $6,485 - $7,236	-63 Reduced 24.9%	190 $20,000
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $5,508 - $7,062	63 Added 33.16%	253 $28,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $9,720 - $10,920	115 Added 153.33%	190 $16,000
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $28,804 - $32,650	-345 Reduced 82.14%	75 $6,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $24,729 - $27,196	345 Added 460.0%	420 $31,000
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $1,757 - $1,944	-25 Reduced 25.0%	75 $5,000
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $7,177 - $7,965	100 New	100 $8,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.